HOMECONTACTSITE MAPSEARCH

Shareholder Briefcase
Request Printed Materials
News and Event Alerts
News Feeds
Search

Investors and Media Relations

The mission of Infinity Pharmaceuticals, Inc. is to discover, develop, and deliver to patients best-in-class medicines for the treatment of cancer and related conditions. We have built a pipeline of innovative product candidates for multiple cancer indications, all of which represent proprietary applications of our expertise in small molecule drug discovery and development.

We believe that our small molecule discovery and development capabilities, strategic alliances, team of highly experienced management and scientists, and corporate culture form the basis of our potential long-term competitive advantage in seeking to deliver best-in-class medicines to patients.

Infinity Pharmaceuticals (NASDAQ: INFI) 4:16 PM ET on Jul 2, 2009
Last Price Change Open Day High 52-Week High
5.42
0.28 down  (4.91%) 5.60 5.79 8.87
Volume Previous Close Day Low 52-Week Low
80,100 5.70 5.40 3.74

Annual Report

Click here to view the 2008 Annual Report


Recent Releases

Jun 29, 2009
Infinity Pharmaceuticals Added to Russell 2000(r) Index

May 30, 2009
Infinity Reports Encouraging Clinical Data for IPI-504 at ASCO 2009

more »

© 2001-2009 Infinity Pharmaceuticals, Inc. All rights reserved. | Terms | Forward Looking Statements | Privacy